Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
4.440
-0.030 (-0.67%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Autolus Therapeutics Employees
As of December 31, 2023, Autolus Therapeutics had 471 total employees, including 463 full-time and 8 part-time employees. The number of employees increased by 67 or 16.58% compared to the previous year.
Employees
471
Change (1Y)
67
Growth (1Y)
16.58%
Revenue / Employee
$22,287
Profits / Employee
-$496,777
Market Cap
1.18B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
The Pennant Group | 5,791 |
agilon health | 1,117 |
CareDx | 643 |
ANI Pharmaceuticals | 642 |
Gyre Therapeutics | 593 |
Collegium Pharmaceutical | 197 |
Pharvaris | 82 |
AUTL News
- 6 weeks ago - Autolus: Start Thinking About Obe-Cel PDUFA -- And The (Baby) Bull Case - Seeking Alpha
- 2 months ago - Autolus Therapeutics plc (AUTL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 - GlobeNewsWire
- 4 months ago - Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress - GlobeNewsWire
- 5 months ago - Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO - GlobeNewsWire
- 5 months ago - Autolus Therapeutics plc (AUTL) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 5 months ago - Autolus Therapeutics: Trading Like Their Products Are Not Valuable, Which Is An Opportunity - Seeking Alpha